Health and medical companies that employ many individuals who are not U.S. citizens seemed unfazed by a change to immigration policies that will increase the amount of time it will take to process their visas.

While biotechnology executives slammed Trump’s executive order barring individuals from seven Muslim-majority countries from traveling to the United States, they have remained mum on a decision by the Department of Homeland Security to temporarily suspend a program that allowed companies to pay a fee to receive visas for employees in 15 days. Normally, it takes months.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • by personal experience, I can say that biotech companies have not been sponsoring visas for international scientists (that are not already in the US on some type of visa) for at least, the past ten years. So, a loss of fast tracking is not really changing the dynamics in any meaningful way

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.